Does vitamin B12 support myelin maintenance and nerve repair, while a high AA:EPA ratio reflects a more pro-inflammatory balance?

Vitamin B12 status and AA:EPA balance are biologically relevant to neural health, but their clinical interpretation differs: B12 deficiency has established neurologic importance, whereas AA:EPA is a contextual biomarker of lipid-mediator potential rather than a diagnostic measure of neuroinflammation.

Vitamin B12 and neural integrity

• B12 is required for methionine synthase and methylmalonyl-CoA mutase, supporting methylation capacity and normal neural lipid metabolism. Deficiency can therefore contribute to myelin injury.
• In 1,019 nondemented older adults in the Rotterdam Scan Study, poorer functional B12 status was dose-dependently associated with more severe cerebral white-matter lesions, particularly periventricular lesions. Higher B12 also predicted slower brain-volume loss over six years in another longitudinal study, though not white-matter-hyperintensity progression.
• Methylcobalamin promotes axonal-growth markers (GAP-43), neurotrophins (NGF, BDNF, CNTF), Schwann-cell differentiation, and remyelination in animal injury models. In humans, correcting deficiency can permit neurologic recovery; evidence does not establish B12 alone as a regenerative therapy for non-deficiency nerve injury.

Lipid mediators and neural inflammation

• AA and EPA compete in cyclooxygenase/lipoxygenase pathways. Higher AA:EPA indicates relatively greater AA substrate availability and a shift toward AA-derived versus EPA-derived mediator potential.
• In supplementation studies, AA:EPA fell from approximately 25:1 to 6.7:1, with increased EPA-derived PGE3, LTB5, and resolvin precursors; EPA/DHA supplementation increased an EPA/DHA-to-AA epoxymetabolite index nearly threefold.
• AA-derived prostaglandins and leukotrienes can activate microglia, which release cytokines, nitric oxide, and PGE2, amplifying neural inflammatory signaling. Conversely, lipoxin A4 and EPA-derived pro-resolving mediators restrain microglial activation in preclinical models.

Bottom line

• Correcting B12 deficiency is important for myelin and neurologic health. A high AA:EPA ratio supports a more pro-inflammatory lipid-mediator potential and plausibly contributes to persistent neural inflammation, but neither B12 supplementation in replete individuals nor the ratio itself proves repair capacity or active human neuroinflammation.